PepTalk 2017
PepTalk 2017

Pipeline Six Icon Pipeline Six Header

Cambridge Healthtech Institute’s Fourth Annual
Single-Use Technologies and Continuous Processing
Advancing Bioprocessing through Technological Innovation
January 9-10, 2017 | Hilton San Diego Bayfront | San Diego, CA

With more than 30 ADCs in clinical trials, and more on the way, antibody-drug conjugates have reached an exciting point in development, particularly with the current next-generation strategies. Cambridge Healthtech Institute’s Antibody-Drug Conjugates conference reveals the engineering that has brought about today’s revolution, and examines how to design safe and effective ADCs. In addition, strategies for advancing ADCs to the clinic will be discussed along with considerations for clinical trial design. Analyzing ADCs to explore conjugation, stability, payloads and tumor penetration will also be addressed in this leading ADC event.

We invite presentation proposals on the following preliminary topics:

Highlighting the Value and Advantages of Single-Use and Continuous Processing

Technological Advantages in Single-Use Technologies and Continuous Processing Equipment

Standardization and Best Practices for Single-Use Technologies and Systems

  • Definition and Benefits of Standardization
  • Areas for Standardization, Guidelines and Best Practices

Challenges to Industrial Adoption and Commercial Implementation

  • Regulatory Challenges
  • Process Complexity and Control Challenges
  • Contamination: Extractables and Leachables
  • Scale and Downstream Process Limitations

Complementing Continuous Processing with Single-Use Technologies

  • Single-Use Perfusion Bioreactors for Upstream Cell Culture

Continuous Processing in Downstream Manufacturing: Overcoming Downstream Scale

Limitations of Single-Use Technologies

Case Studies of Continuous Processing

Challenges and Limitations in Continuous Processing

Designing the Facility of the Future – Disposable, Continuous and Modular


Please click here to submit a speaking proposal for review.

Deadline for submission: May 27, 2016

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions about the meeting, please contact:
Kip Harry
Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5454
Email: kharry@healthtech.com

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com